Quartzy Raises $23M to Scale Procurement and Supply Chain Platform for Life Sciences Labs
Funding Details
$23M
In labs pushing the edge of human knowledge, the biggest constraint isn’t intelligence, it’s friction, the kind that hides in supply closets, approval chains, and missing inventory, quietly draining momentum while no one puts it on the quarterly report.
Jayant Kulkarni and Adam Regelmann saw that mess up close at Columbia University, not as tourists but as participants, and built Quartzy not as another piece of software but as a system that actually understands how labs breathe, connecting inventory, ordering, approvals, and fulfillment so scientists can get back to doing science instead of playing procurement roulette.
Now Quartzy just pulled in $23M, with Avenue Capital Group and BroadOak Capital Partners stepping in like they’ve read the same playbook and decided inefficiency isn’t a personality trait but a fixable problem.
Over 3,000 organizations are already plugged into Quartzy’s ecosystem, with more than 10M products from over 1,000 suppliers flowing through the platform, which starts to look less like a catalog and more like a supply chain with a brain.
This isn’t software sitting politely on top of a broken process, this is Quartzy going vertical across marketplace, logistics, and workflow, removing friction instead of managing it and letting the results speak in throughput, time saved, and fewer headaches in labs that don’t have time for excuses.
That kind of move comes from founders who lived the pain, understood the buyer, and built something people actually use, which is a quiet reminder that if you’re not embedded in the workflow, you’re just noise dressed up as innovation.
This $23M isn’t about survival, it’s about pressure, expanding the supplier network, sharpening the platform, and tightening the go-to-market engine in ways that turn a useful tool into infrastructure. And infrastructure doesn’t ask for attention, it becomes unavoidable, which is exactly where Quartzy is positioning itself whether the market is ready to admit it or not.